... There are also biological factors that may come into play.MelphalanMelphalan (Alkeran) is a chemotherapy drug used in the treatment of multiple myeloma. ...
... There are also biological factors that may come into play.MelphalanMelphalan (Alkeran) is a chemotherapy drug used in the treatment of multiple myeloma. ...
... classes of medications include chemotherapy, immunomodulatory drugs, corticosteroids, histone deacetylase (HDAC) inhibitors, monoclonal antibodies, proteasome inhibitors, and bisphosphonates.ChemotherapyChemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells.Chemotherapy drugs include: Adriamycin (doxorubicin) Alkeran ...
... classes of medications include chemotherapy, immunomodulatory drugs, corticosteroids, histone deacetylase (HDAC) inhibitors, monoclonal antibodies, proteasome inhibitors, and bisphosphonates.ChemotherapyChemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells.Chemotherapy drugs include: Adriamycin (doxorubicin) Alkeran ...
... For this procedure, a person’s stem cells (cells that make new blood cells) are replaced — preceded by a high dose of the chemotherapy drug melphalan (Alkeran).People with multiple myeloma may need additional treatments that are not usually used for amyloidosis. ...
... For this procedure, a person’s stem cells (cells that make new blood cells) are replaced — preceded by a high dose of the chemotherapy drug melphalan (Alkeran).People with multiple myeloma may need additional treatments that are not usually used for amyloidosis. ...
... Such drugs include proteasome inhibitors — carfilzomib (Kyprolis), bortezomib (Velcade), and ixazomib (Ninlaro) and alkylating agents — cyclophosphamide (Cytoxan), melphalan (Alkeran), and bendamustine (Treanda).Radiation TherapyAs with chemotherapy, radiation therapy (also called radiotherapy) can increase a person’s risk of developing infections due ...
... Such drugs include proteasome inhibitors — carfilzomib (Kyprolis), bortezomib (Velcade), and ixazomib (Ninlaro) and alkylating agents — cyclophosphamide (Cytoxan), melphalan (Alkeran), and bendamustine (Treanda).Radiation TherapyAs with chemotherapy, radiation therapy (also called radiotherapy) can increase a person’s risk of developing infections due ...
... Alkylating agents approved to treat multiple myeloma include: Melphalan (Alkeran) Carmustine (BiCNU) Cyclophosphamide (Cytoxan) Vincristine (formerly sold as Oncovin) Melphalan flufenamide (Pepaxto) Bendamustine (Treanda) AnthracyclinesChemotherapy drugs called anthracyclines also damage DNA and prevent cells from dividing. ...
... Alkylating agents approved to treat multiple myeloma include: Melphalan (Alkeran) Carmustine (BiCNU) Cyclophosphamide (Cytoxan) Vincristine (formerly sold as Oncovin) Melphalan flufenamide (Pepaxto) Bendamustine (Treanda) AnthracyclinesChemotherapy drugs called anthracyclines also damage DNA and prevent cells from dividing. ...
... This may be called conditioning treatment.Conditioning treatment usually consists of high doses of Alkeran (melphalan), a chemotherapy drug. You receive chemotherapy through a catheter (small tube placed into your chest). These treatments destroy most of your myeloma cells and make more room for new stem cells in the bone marrow. ...
... This may be called conditioning treatment.Conditioning treatment usually consists of high doses of Alkeran (melphalan), a chemotherapy drug. You receive chemotherapy through a catheter (small tube placed into your chest). These treatments destroy most of your myeloma cells and make more room for new stem cells in the bone marrow. ...
... The alkylating agents melphalan (Alkeran) and cyclophosphamide are commonly used to treat people with myeloma, as are the anthracyclines doxorubicin and liposomal doxorubicin (Doxil). If you already have heart disease, your doctor may deem myeloma treatments that can affect the heart to be of higher risk for you. ...
... The alkylating agents melphalan (Alkeran) and cyclophosphamide are commonly used to treat people with myeloma, as are the anthracyclines doxorubicin and liposomal doxorubicin (Doxil). If you already have heart disease, your doctor may deem myeloma treatments that can affect the heart to be of higher risk for you. ...
... They include melphalan (Alkeran, Evolema), cyclophosphamide, carmustine (BiCNU), and bendamustine (Treanda). Anthracyclines — These treatments slow the growth of cancer cells by interfering with cell division. They include doxorubicin and doxorubicin liposome (Doxil). ...
... They include melphalan (Alkeran, Evolema), cyclophosphamide, carmustine (BiCNU), and bendamustine (Treanda). Anthracyclines — These treatments slow the growth of cancer cells by interfering with cell division. They include doxorubicin and doxorubicin liposome (Doxil). ...
Join